Eli Lilly and Company (LILY)
GPW
4,640.00
0.00 (0.00%)
Real-time Data
07:00 AM
Day's Range
4,640.004,640.00
52 wk Range
3,151.504,643.50
Financial Statements - LILY - Eli Lilly and Company
Revenue
65.17B
Net Income
20.64BNet Margin 31.7%
EBITDA
35.08B
Free Cash Flow
5.96B
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 65.17B |
| Cost of Goods | 11.05B |
| Gross Profit | 54.12B |
 Operating Expense | - |
| Operating Income | 29.69B |
| Non-Operating Interest | - |
| Other Income Expense | -3.96B |
| Pre Tax Income | 25.73B |
| Income Tax | 5.09B |
| Net Income | 20.64B |
| EPS Basic | 23 |
| EPS Diluted | 22.95 |
| Basic Shares Outstanding | 897.30M |
| Diluted Shares Outstanding | 897.30M |
| Ebit | 29.69B |
| Ebitda | 35.08B |
| Net Income Continuous Operations | 20.64B |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
